Effect of continuous positive airway pressure on insulin growth factor-1 in patients with obstructive sleep apnea: A meta-analysis

Ryan, 1985, Pathogenesis of obstructive sleep apnea, J. Appl. Physiol., 99, 2440 Young, 1993, The occurrence of sleep-disordered breathing among middle-aged adults, N. Engl. J. Med., 328, 1230, 10.1056/NEJM199304293281704 Lindberg, 2000, Epidemiology of sleep-related obstructive breathing, Sleep Med. Rev., 4, 411, 10.1053/smrv.2000.0118 Lanfranco, 2010, Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update, J. Endocrinol. Investig., 33, 192, 10.1007/BF03346580 Humbel, 1990, Insulin-like growth factors I and II, Eur. J. Biochem./FEBS, 190, 445, 10.1111/j.1432-1033.1990.tb15595.x Tapanainen, 1992, Evaluation of growth hormone secretion and treatment, Ann. Med., 24, 237, 10.3109/07853899209149951 Ursavas, 2007, Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome, Lung, 185, 309, 10.1007/s00408-007-9026-x Grunstein, 1989, Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy, J. Clin. Endocrinol. Metab., 68, 352, 10.1210/jcem-68-2-352 McArdle, 2007, Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study, Am. J. Respir. Crit. Care Med., 175, 190, 10.1164/rccm.200602-270OC Meston, 2003, Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea, J. Intern. Med., 254, 447, 10.1046/j.1365-2796.2003.01212.x Makino, 2012, Plasma dehydroepiandrosterone sulphate and insulin-like growth factor I levels in obstructive sleep apnoea syndrome, Clin. Endocrinol., 76, 593, 10.1111/j.1365-2265.2011.04237.x Lindberg, 2006, CPAP treatment of a population-based sample—what are the benefits and the treatment compliance?, Sleep Med., 7, 553, 10.1016/j.sleep.2005.12.010 Brooks, 1994, Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness, J. Clin. Endocrinol. Metab., 79, 1681 Barcelo, 2008, Insulin resistance and daytime sleepiness in patients with sleep apnoea, Thorax, 63, 946, 10.1136/thx.2007.093740 Munzer, 2010, Effects of long-term continuous positive airway pressure on body composition and IGF1, Eur. J. Endocrinol./Eur. Fed. Endocr. Soc., 162, 695, 10.1530/EJE-09-0919 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Dickersin, 1992, Meta-analysis: state-of-the-science, Epidemiol. Rev., 14, 154, 10.1093/oxfordjournals.epirev.a036084 Mysliwiec, 2013, Prospective observational study of military personnel with obstructive sleep apnea: changes in symptoms of service related illnesses and IGF-1 expression, Chest, 144, 10.1378/chest.1701557 Muenzer, 2010, Effects of long-term continuous positive airway pressure on body composition and IGF1, Eur. J. Endocrinol., 162, 695, 10.1530/EJE-09-0919 Saini, 1993, Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients, Horm. Metab. Res. Horm. Stoffwechselforschung Horm. Metab., 25, 375, 10.1055/s-2007-1002123 Hoyos, 2014, Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: A randomized sham-controlled study, Sleep, 733, 10.5665/sleep.3580 Duarte, 2013, The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly, Pituitary, 16, 341, 10.1007/s11102-012-0430-8 Harsch, 2003, Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment, Eur. Respir. J., 22, 251, 10.1183/09031936.03.00010103 Makino, 2012, Plasma dehydroepiandrosterone sulphate and insulin-like growth factor I levels in obstructive sleep apnoea syndrome, Clin. Endocrinol., 76, 593, 10.1111/j.1365-2265.2011.04237.x Lindberg, 2006, CPAP treatment of a population-based sample-what are the benefits and the treatment compliance?, Sleep Med., 7, 553, 10.1016/j.sleep.2005.12.010 Issa, 1986, The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome, Electroencephalogr. Clin. Neurophysiol., 63, 10, 10.1016/0013-4694(86)90056-8 Zhang, 2000, The response of growth hormone and prolactin of rats to hypoxia, Neurosci. Lett., 279, 137, 10.1016/S0304-3940(99)00968-4 Han, 1998, Insulin-like growth factor binding proteins in air- and 85% oxygen-exposed adult rat lung, Am. J. Physiol., 274, L647 Polo, 1994, Management of obstructive sleep apnoea/hypopnoea syndrome, Lancet, 344, 656, 10.1016/S0140-6736(94)92089-3 Chami, 2011, Association of incident cardiovascular disease with progression of sleep-disordered breathing, Circulation, 123, 1280, 10.1161/CIRCULATIONAHA.110.974022 Marin, 2005, Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study, Lancet, 365, 1046, 10.1016/S0140-6736(05)71141-7 Kraiczi, 2001, Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep, Chest, 119, 1085, 10.1378/chest.119.4.1085 Juul, 2002, Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case–control study, Circulation, 106, 939, 10.1161/01.CIR.0000027563.44593.CC Janssen, 1998, Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease, Arterioscler. Thromb. Vasc. Biol., 18, 277, 10.1161/01.ATV.18.2.277 Akerstedt, 1980, Adrenocortical and gonadal steroids during sleep deprivation, Sleep, 3, 23, 10.1093/sleep/3.1.23 Quabbe, 1985, Hypothalamic control of GH secretion: pathophysiology and clinical implications, Acta Neurochir., 75, 60, 10.1007/BF01406324